Cargando…
Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden
AIMS/HYPOTHESIS: The risk of complications and medical consequences of type 2 diabetes are well known. Hospital costs have been identified as a key driver of total costs in studies of the economic burden of type 2 diabetes. Less evidence has been generated on the impact of individual diabetic compli...
Autores principales: | Andersson, Emelie, Persson, Sofie, Hallén, Nino, Ericsson, Åsa, Thielke, Desirée, Lindgren, Peter, Steen Carlsson, Katarina, Jendle, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641955/ https://www.ncbi.nlm.nih.gov/pubmed/32968866 http://dx.doi.org/10.1007/s00125-020-05277-3 |
Ejemplares similares
-
Model‐based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease
por: Nilsson, Kristoffer, et al.
Publicado: (2022) -
Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden
por: Jendle, Johan, et al.
Publicado: (2017) -
Smart Insulin Pens are Associated with Improved Clinical Outcomes at Lower Cost Versus Standard-of-Care Treatment of Type 1 Diabetes in Sweden: A Cost-Effectiveness Analysis
por: Jendle, Johan, et al.
Publicado: (2020) -
Burden of established cardiovascular disease in people with type 2 diabetes and matched controls: Hospital‐based care, days absent from work, costs and mortality
por: Persson, Sofie, et al.
Publicado: (2022) -
MON-392 Bone Health in Diabetes - Are We Addressing It?
por: Thapa, Rachana, et al.
Publicado: (2020)